Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 88 (RPL21P88)

Target: RPL21P88
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L21 pseudogene 88 (RPL21P88) is a non-functional, processed pseudogene derived from the functional ribosomal protein L21 gene. Pseudogenes are essentially genetic remnants, typically arising through gene duplication or retrotransposition, and do not produce functional proteins. RPL21P88 is catalogued in human genome databases, but unlike its parental gene RPL21, it does not contribute to ribosomal structure, translation, or known disease processes. It is not considered a druggable target, nor does it play a role in molecular pharmacology or clinical biomarkers[1][3][5][7].

Other names: RPL21_36_1036RPL21P88

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 88 (RPL21P88).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 88 (RPL21P88).

Explore the full profile